 |
Professor Alan Isles MB BS (Hons), MSc, FRACP, FRCP (C)
Professor Alan Isles is a Senior Paediatrician at the Royal Children’s Hospital and a founding board member of the Queensland Children’s Medical Research Institute.
Professor Isles completed his medical training at the University of Queensland and began working at the Royal Children’s Hospital, Brisbane, in 1975. Training in paediatrics at the Royal Children’s Hospital, he then spent four years at Toronto’s Hospital for Sick Children where he undertook advanced training and research in clinical pharmacology and paediatric respiratory medicine.
Professor Isles returned to the Royal Children’s Hospital in 1984, was appointed to the Board of the Royal Children’s Hospital Foundation in July 1997. From 1998 until 2006 he was the District Manager of the Royal Children's Hospital and Health Service District. From 2006 to 2008 he led the initial phase of planning for the future Queensland Children’s Hospital.
Professor Isles is a Fellow of the Royal Australasian College of Physicians and the Royal Canadian College of Physicians. In 2007, he was awarded the Royal Children's Hospital and Health Service District's Medal of Distinction and in December 2008 was awarded the Royal Children’s Hospital Foundation’s inaugural Medal of Excellence for Service to Paediatrics.
|
 |
Michael Mullins LLB, MBA, F Fin (Acting Chairman)
Michael Mullins is currently Director of a private equity company, Valesco Capital Pty Ltd. He is a Solicitor to the Supreme Court of Queensland and Fellow of FINSIA.
He is a Consultant with Mullins Lawyers, where he developed extensive experience in the areas of property, intellectual property, banking and finance, franchising and business sales and acquisitions. He was a founder in 1994 of software company, Business Support Systems Pty Ltd, and in 1999 – 2001 he was Director /Secretary of Peplin Limited, an ASX listed company. In 2006, Mr Mullins founded Earth Commodities Pty Ltd, the largest independent quarry group in Queensland.
As a serial entrepreneur, his specialist expertise includes project structuring and strategic planning, managing numerous property development projects. He is a former Brisbane Chapter President of the Entrepreneurs’ Organization and in 2005-2006 was The Entrepreneurs’ Organization International President and Chairman of the board of directors.
Mr Mullins is a long serving member of the Royal Children’s Hospital Foundation Grants Committee. Michael Mullins is a founding board member of the Queensland Children’s Medical Research Institute.
|
 |
Dr John O’Donnell MB BS, Dip.RACOG, MHP, FRACMA, AFACHSE, FAIM, FAICD
Dr John O’Donnell is Chief Executive Officer, Mater Health Services Brisbane Ltd. Following medical training in South Australia, and some years in general practice, he was appointed Assistant Medical Director, Royal Adelaide Hospital and Medical Director, Hampstead Centre Rehabilitation Hospital. He was then appointed to the position of Deputy Medical Director of Royal Adelaide Hospital. From 1990-1994, he held the positions of Executive Director, Clinical Services and Deputy General Manager of Australian Capital Territory Health Services at Royal Canberra and Woden Valley Hospitals.
Dr O’Donnell then moved to the private sector and over the following 7 years was appointed to the positions of Commissioning Chief Executive, Port Macquarie Hospitals; CEO, St George Private Hospital and CEO, Prince of Wales Private Hospital; and then Chief Operating Officer of Health Care of Australia’s 10 metropolitan Sydney hospitals. Concurrently, Dr O’Donnell had a key strategic and policy role within the Mayne Nickless E-commerce and strategic planning teams, before appointment as National Director of Clinical Services and Quality for the 61 public and private Mayne Nickless Limited hospitals, which traded under the HCOA and later Mayne Health brands in Australia, Indonesia and Fiji.
With a range of high profile health care clients, he directed John O’Donnell & Associates, Health Service Management Consultants from early 2001 until appointment to his current position as CEO of Mater Misericordiae Health Service Brisbane Ltd in November 2001.
Dr O’Donnell has also had a strong involvement in a number of community, professional service and teaching activities. He is a Fellow of the Australian Institute of Company Directors, and The Australian Institute of Management, an Associate Fellow of the Australian College of Health Service Executives, and also holds a Fellowship with the Royal Australian College of Medical Administrators.Dr O’Donnell holds appointments as Adjunct Professor, School of Medicine, Faculty of Health Sciences, University of Queensland and Adjunct Professor, Department of International Business and Asian Studies, Griffith Business School. Dr O’Donnell is Chair of Mercy Super Ltd. and a director of Mater Appeals Ltd (the Mater Foundation), the Mater Medical Research Institute Ltd, the Health Round Table Ltd. and is a founding board member of the Queensland Children’s Medical Research Institute.
|
 |
Professor Ross Pinkerton
Ross Pinkerton is senior staff specialist in paediatric oncology at the Royal Children’s Hospital, Brisbane and Executive Director of the Division of Cancer in the Children’s Health Services District.
He graduated from the Queens University Belfast and trained in paediatrics in Dublin and London. As Leukemia Research Fund clinical fellow at the Hospital for Sick Children Great Ormond Street between 1982-84 he was involved in the development of treatment programmes for a range of childhood cancers. In 1985-86 he worked at the Centre Leon Berard, Lyon, investigating the role of high dose therapy and autologous stem cell rescue and the use of chemotherapy purging of reinfused marrow. He returned to the Royal Marsden Hospital, London and was appointed consultant paediatric oncologist in 1990 and was involved in the development of the children’s cancer service and the research facility at the Institute of Cancer Research.
He was appointed Cancer Research UK professor of paediatric oncology at the Institute in 1995 and chaired the United Kingdom Children’s Cancer Study Group (UKCCSG) from 1999-2002. In this role he was responsible for the coordination of national clinical trials and establishing links with other European and international trials groups.
His research interests have focussed on the development of novel chemotherapy strategies and the mechanism of drug resistance in children’s cancers.
He has played an active role in the development and execution of national and international clinical trials in a range of paediatric tumour types and chaired the UKCCSG New Agents group. The latter was the first European group to institute Phase 1 trials in children with cancer.
He is the author of over 250 peer reviewed papers and is editor of five textbooks including ‘Evidence Based Paediatic Oncology’ and ‘Paediatric Oncology.’
In 2003 he moved to Australia as director of cancer services at the Mater Hospital Brisbane and Professor of Oncology at the University of Queensland and moved to the Royal Children’s Hospital in 2007.
Professor Pinkerton is currently clinical leader of the Queensland Paediatric Haematology Oncology Network and chairs the Statewide Child and Youth Clinical Network. He is a board member of the national children’s cancer charity, RedKite.
|
|
|
Ms Denisse Best BA Social Work, Grad Cert Health Mgt
Denisse is the current District Clinical Leader - Allied Health, Children's Health Services.
Denisse, originally trained and worked as a social worker before moving into management and executive roles and completing a graduate certificate in health management. Fostering new approaches and seeing services grow and change to better meet the challenges of increasing demand and expectations has been a theme of her work.
Developing the Children’s Health Service and being part of a once in a generation opportunity bringing to life the Queensland Children’s Hospital along with community health services is both challenging and rewarding. Health care is a rapidly changing area and allied health will continue to contribute to strong team care approaches and increasingly re-orientate the system of care to one that works in greater partnership with families and patients.
As a member of the executive team with an emphasis on clinical leadership the role is diverse and broad along with specific accountability for developing the clinical services and supports needed into the future. Allied health roles, services, workforce, models of practice and strategic alignment within the District and within the wider health system are all areas of responsibility.
|
 |
Ms Tracey Hunter BA, MBA
Tracey Hunter is CEO of the Royal Children’s Hospital Foundation and the newly established Children’s Health Foundation Queensland.
Tracey has a background that spans both the corporate and not-for-profit sectors within Australia and internationally. Having spent fifteen years in senior leadership roles within the IT industry, Tracey moved to the not-for-profit sector as Director of Marketing at the Wesley Hospital. After four years in that role leading marketing and fundraising, including establishing the highly successful Think Pink campaign, Tracey shifted focus to international humanitarian projects. She has worked across the Pacific, Indonesia, and the Middle East, running large scale development and disaster recovery projects, funded by international governments and the United Nations.
A key element of Tracey’s leadership strength lies in establishing new business, new campaigns, and change management. In Tracey’s current role she is responsible for the amalgamation of the Royal Children’s Hospital Foundation and the Children’s Health Foundation Queensland.
|